[View original text]

On 1st of December, AIDOT, a medical artificial intelligence company, announced that Cerviray, an artificial intelligence-based cervical cancer artificial intelligence solution, has 

completed ISO13485 certification, an international quality management system standard.

Through this certification, while AIDOT preparing an opportunity to more aggressively promote and supply Cerviray systems to Southeast Asian and South American countries that are currently pioneering, expected that the way to officially export products to these countries will be opened.

European CE certification is also planned to be completed soon.

AIDOT has participated in several international online exhibitions and road shows this year, signed supply contracts with medical healthcare companies in Vietnam, Paraguay, and 

India, and has secured export performance of more than 3 billion won in the first half of 2021.

In addition, through overseas IR and roadshows hosted by the Seoul Metropolitan Government, Korea International Trade Association, and Korea Trade-Investment Promotion Agency (KOTRA), AIDOT held meetings with 40 companies in 16 countries and secured potential customers from 25 companies in 11 countries.

An AIDOT official explained, "We have completed all preparations including certification procedures so that Cerviray can be supplied immediately, including ISO13485. This is a case in which domestic AI medical ICT solutions were recognized overseas and led to actual exports.”

Aidot received the ‘Technology Guarantee Fund Chairman Award’ at the 1st Smart Korea Grand Prize this year, and won the ‘TTA Chairman Award’ at the 7th Korea SW Product Quality Awards.

In addition, the company is announcing successive awards, such as the confirmation of the 2020 Minister of Small and Medium Business Ventures Award.

AIDOT CEO Jae-hoon Jeong said, “Cerviray, which has been verified in the overseas market, is scheduled to enter the domestic medical market in the first half of 2021, and we will 

make efforts to make Cerviray a model that can coexist with domestic medical staff.”

01st. Dec. 2020. 18:07 / Korea Economic Daily